Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)

Martin Ramsden, Linda Kotilinek, Colleen Forster, Jennifer Paulson, Eileen McGowan, Karen SantaCruz, Aaron Guimaraes, Mei Yue, Jada Lewis, George Carlson, Michael Hutton, Karen H Ashe

Research output: Contribution to journalArticle

329 Citations (Scopus)

Abstract

Here, we describe the generation of a novel transgenic mouse model of human tauopathy. The rTg(tauP301L)4510 mouse expresses the P301L mutation in tau (4R0N) associated with frontotemporal dementia and parkinsonism linked to chromosome 17. Transgene expression was driven by a forebrain-specific Ca 2+ calmodulin kinase II promoter system resulting in high levels of expression in the hippocampus and neocortex. Importantly, transgene expression in this model is induced via the tetracycline-operon responsive element and is suppressed after treatment with doxycycline. Continued transgene expression in rTg(tauP301L)4510 mice results in age-dependent development of many salient characteristics of hereditary human dementia. From an early age, immunohistochemical studies demonstrated abnormal biochemical processing of tau and the presence of pathological conformation- and phosphorylation-dependent epitopes. Neurofibrillary tangle (NFT) pathology was first observed in the neocortex and progressed into the hippocampus and limbic structures with increasing age. Consistent with the formation of NFTs, immunoblots indicated an age-dependent transition of accumulating tau species from Sarkosyl soluble 55 kDa to insoluble hyperphosphorylated 64 kDa. Ultrastructural analysis revealed the presence of straight tau filaments. Furthermore, the effects of tau P301L expression on spatial reference memory were longitudinally tested using the Morris water maze. Compared with nontransgenic age-matched control littermates, rTg(tauP301L)4510 mice developed significant cognitive impairments from 4 months of age. Memory deficits were accompanied by gross forebrain atrophy and a prominent loss of neurons, most strikingly in hippocampal subdivision CA1. Collectively, these data describe a novel transgenic mouse that closely mimics human tauopathy and may represent an important model for the future study of tau-related neurodegenerative disease.

Original languageEnglish (US)
Pages (from-to)10637-10647
Number of pages11
JournalJournal of Neuroscience
Volume25
Issue number46
DOIs
StatePublished - Nov 16 2005

Fingerprint

Tauopathies
Neurofibrillary Tangles
Memory Disorders
Transgenes
Neocortex
Prosencephalon
Neurons
Transgenic Mice
Hippocampus
Frontotemporal Dementia
Calcium-Calmodulin-Dependent Protein Kinases
Chromosomes, Human, Pair 17
Doxycycline
Operon
Tetracycline
Neurodegenerative Diseases
Atrophy
Dementia
Epitopes
Phosphorylation

Keywords

  • Alzheimer
  • FTDP-17
  • Hippocampus
  • Neurodegeneration
  • Tau
  • Transgenic

Cite this

Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). / Ramsden, Martin; Kotilinek, Linda; Forster, Colleen; Paulson, Jennifer; McGowan, Eileen; SantaCruz, Karen; Guimaraes, Aaron; Yue, Mei; Lewis, Jada; Carlson, George; Hutton, Michael; Ashe, Karen H.

In: Journal of Neuroscience, Vol. 25, No. 46, 16.11.2005, p. 10637-10647.

Research output: Contribution to journalArticle

Ramsden, M, Kotilinek, L, Forster, C, Paulson, J, McGowan, E, SantaCruz, K, Guimaraes, A, Yue, M, Lewis, J, Carlson, G, Hutton, M & Ashe, KH 2005, 'Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)', Journal of Neuroscience, vol. 25, no. 46, pp. 10637-10647. https://doi.org/10.1523/JNEUROSCI.3279-05.2005
Ramsden, Martin ; Kotilinek, Linda ; Forster, Colleen ; Paulson, Jennifer ; McGowan, Eileen ; SantaCruz, Karen ; Guimaraes, Aaron ; Yue, Mei ; Lewis, Jada ; Carlson, George ; Hutton, Michael ; Ashe, Karen H. / Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). In: Journal of Neuroscience. 2005 ; Vol. 25, No. 46. pp. 10637-10647.
@article{2d1fca2e081f40809d0b02dd691ef931,
title = "Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)",
abstract = "Here, we describe the generation of a novel transgenic mouse model of human tauopathy. The rTg(tauP301L)4510 mouse expresses the P301L mutation in tau (4R0N) associated with frontotemporal dementia and parkinsonism linked to chromosome 17. Transgene expression was driven by a forebrain-specific Ca 2+ calmodulin kinase II promoter system resulting in high levels of expression in the hippocampus and neocortex. Importantly, transgene expression in this model is induced via the tetracycline-operon responsive element and is suppressed after treatment with doxycycline. Continued transgene expression in rTg(tauP301L)4510 mice results in age-dependent development of many salient characteristics of hereditary human dementia. From an early age, immunohistochemical studies demonstrated abnormal biochemical processing of tau and the presence of pathological conformation- and phosphorylation-dependent epitopes. Neurofibrillary tangle (NFT) pathology was first observed in the neocortex and progressed into the hippocampus and limbic structures with increasing age. Consistent with the formation of NFTs, immunoblots indicated an age-dependent transition of accumulating tau species from Sarkosyl soluble 55 kDa to insoluble hyperphosphorylated 64 kDa. Ultrastructural analysis revealed the presence of straight tau filaments. Furthermore, the effects of tau P301L expression on spatial reference memory were longitudinally tested using the Morris water maze. Compared with nontransgenic age-matched control littermates, rTg(tauP301L)4510 mice developed significant cognitive impairments from 4 months of age. Memory deficits were accompanied by gross forebrain atrophy and a prominent loss of neurons, most strikingly in hippocampal subdivision CA1. Collectively, these data describe a novel transgenic mouse that closely mimics human tauopathy and may represent an important model for the future study of tau-related neurodegenerative disease.",
keywords = "Alzheimer, FTDP-17, Hippocampus, Neurodegeneration, Tau, Transgenic",
author = "Martin Ramsden and Linda Kotilinek and Colleen Forster and Jennifer Paulson and Eileen McGowan and Karen SantaCruz and Aaron Guimaraes and Mei Yue and Jada Lewis and George Carlson and Michael Hutton and Ashe, {Karen H}",
year = "2005",
month = "11",
day = "16",
doi = "10.1523/JNEUROSCI.3279-05.2005",
language = "English (US)",
volume = "25",
pages = "10637--10647",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "46",

}

TY - JOUR

T1 - Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)

AU - Ramsden, Martin

AU - Kotilinek, Linda

AU - Forster, Colleen

AU - Paulson, Jennifer

AU - McGowan, Eileen

AU - SantaCruz, Karen

AU - Guimaraes, Aaron

AU - Yue, Mei

AU - Lewis, Jada

AU - Carlson, George

AU - Hutton, Michael

AU - Ashe, Karen H

PY - 2005/11/16

Y1 - 2005/11/16

N2 - Here, we describe the generation of a novel transgenic mouse model of human tauopathy. The rTg(tauP301L)4510 mouse expresses the P301L mutation in tau (4R0N) associated with frontotemporal dementia and parkinsonism linked to chromosome 17. Transgene expression was driven by a forebrain-specific Ca 2+ calmodulin kinase II promoter system resulting in high levels of expression in the hippocampus and neocortex. Importantly, transgene expression in this model is induced via the tetracycline-operon responsive element and is suppressed after treatment with doxycycline. Continued transgene expression in rTg(tauP301L)4510 mice results in age-dependent development of many salient characteristics of hereditary human dementia. From an early age, immunohistochemical studies demonstrated abnormal biochemical processing of tau and the presence of pathological conformation- and phosphorylation-dependent epitopes. Neurofibrillary tangle (NFT) pathology was first observed in the neocortex and progressed into the hippocampus and limbic structures with increasing age. Consistent with the formation of NFTs, immunoblots indicated an age-dependent transition of accumulating tau species from Sarkosyl soluble 55 kDa to insoluble hyperphosphorylated 64 kDa. Ultrastructural analysis revealed the presence of straight tau filaments. Furthermore, the effects of tau P301L expression on spatial reference memory were longitudinally tested using the Morris water maze. Compared with nontransgenic age-matched control littermates, rTg(tauP301L)4510 mice developed significant cognitive impairments from 4 months of age. Memory deficits were accompanied by gross forebrain atrophy and a prominent loss of neurons, most strikingly in hippocampal subdivision CA1. Collectively, these data describe a novel transgenic mouse that closely mimics human tauopathy and may represent an important model for the future study of tau-related neurodegenerative disease.

AB - Here, we describe the generation of a novel transgenic mouse model of human tauopathy. The rTg(tauP301L)4510 mouse expresses the P301L mutation in tau (4R0N) associated with frontotemporal dementia and parkinsonism linked to chromosome 17. Transgene expression was driven by a forebrain-specific Ca 2+ calmodulin kinase II promoter system resulting in high levels of expression in the hippocampus and neocortex. Importantly, transgene expression in this model is induced via the tetracycline-operon responsive element and is suppressed after treatment with doxycycline. Continued transgene expression in rTg(tauP301L)4510 mice results in age-dependent development of many salient characteristics of hereditary human dementia. From an early age, immunohistochemical studies demonstrated abnormal biochemical processing of tau and the presence of pathological conformation- and phosphorylation-dependent epitopes. Neurofibrillary tangle (NFT) pathology was first observed in the neocortex and progressed into the hippocampus and limbic structures with increasing age. Consistent with the formation of NFTs, immunoblots indicated an age-dependent transition of accumulating tau species from Sarkosyl soluble 55 kDa to insoluble hyperphosphorylated 64 kDa. Ultrastructural analysis revealed the presence of straight tau filaments. Furthermore, the effects of tau P301L expression on spatial reference memory were longitudinally tested using the Morris water maze. Compared with nontransgenic age-matched control littermates, rTg(tauP301L)4510 mice developed significant cognitive impairments from 4 months of age. Memory deficits were accompanied by gross forebrain atrophy and a prominent loss of neurons, most strikingly in hippocampal subdivision CA1. Collectively, these data describe a novel transgenic mouse that closely mimics human tauopathy and may represent an important model for the future study of tau-related neurodegenerative disease.

KW - Alzheimer

KW - FTDP-17

KW - Hippocampus

KW - Neurodegeneration

KW - Tau

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=27944491109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27944491109&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3279-05.2005

DO - 10.1523/JNEUROSCI.3279-05.2005

M3 - Article

C2 - 16291936

AN - SCOPUS:27944491109

VL - 25

SP - 10637

EP - 10647

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 46

ER -